Global Medical Manager
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Gå tilbage til ledige stillinger
Global Medical Manager
Pioneer the development of a new class of drugs halting disease progression and restoring function
https://uhc.dk/wp-content/uploads/2023/09/Global-Medical-Manager-Vicore-Pharma.mp4
As Global Medical Manager at Vicore Pharma you will be the responsible physician for clinical trials, overseeing patient safety, reviewing clinical data, and providing guidance on medical issues for Vicore’s lead candidate drug in idiopathic pulmonary fibrosis.
With direct report to CMO Rohit Batta.
Your main responsibilities include:
Your qualifications include over three years of experience in the pharmaceutical and/or biotechnology industry, where you have been actively involved in the clinical development of investigational new drugs. This experience extended to your role as the Sponsor’s medical expert, where you have been responsible for overseeing trials managed through global clinical outsourcing. Additionally, you have contributed to regulatory documents and submissions, and engaged in interactions with health authorities.
You are a medical doctor with hands-on pulmonology/ILD trial experience.
You are a person who possesses a dynamic combination of qualities, including initiative, organizational skills, and the ability to seamlessly handle multiple tasks. Your communication style is characterized by clarity, making you an adept leader in scientific and clinical settings. Your proactive approach, commitment, and energy set you apart. With exceptional problem-solving abilities and a “can-do attitude,” you thrive in challenging situations. Furthermore, your open and approachable personality makes you a pleasure to work with.
Vicore Pharma is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs, angiotensin II type 2 receptor agonists (ATRAG), for severe diseases.
Vicore has a unique expertise in the ATRAG biology and a holistic approach in diseases where the angiotensin II type 2 receptor has a central role in stopping and reversing disease pathology. Vicore’s pipeline has several assets with long patent life for a variety of diseases. Our lead indication is idiopathic pulmonary fibrosis and our most advanced candidate drug, C21, is currently completing a phase 2a clinical trial and preparing for the next phase.
Vicore is a lean and agile organization with highly experienced professionals who cover the entire spectrum from early asset development through to commercialization and patient access. Vicore’s success hinges on the capacity to attract and retain talented individuals who are deeply committed, adaptable to change, and thrive in a dynamic environment with ambitious goals. All employees are equally important to turn the Vicore ambition into reality. Through valuing trust, integrity, and an open, friendly, and informal atmosphere, you can expect great opportunities for impact and growth.
Travelling: Approx. 10 days per year.
Domicile: Commuting distance from the Vicore office in Hørsholm, Copenhagen.
For more details about the job or the company, please contact Director Life Science Gert Andersen, Unique Human Capital on M: +45 42 95 08 83, [email protected].
All applications must be in English and are treated confidentially.
Global Medical Manager
Pioneer the development of a new class of drugs halting disease progression and restoring function
https://uhc.dk/wp-content/uploads/2023/09/Global-Medical-Manager-Vicore-Pharma.mp4
As Global Medical Manager at Vicore Pharma you will be the responsible physician for clinical trials, overseeing patient safety, reviewing clinical data, and providing guidance on medical issues for Vicore’s lead candidate drug in idiopathic pulmonary fibrosis.
With direct report to CMO Rohit Batta.
Your main responsibilities include:
- Serving as a core member of the trial team
- Medical responsibility for the clinical trials with active participation in patient eligibility assessment, study design questions, and addressing urgent safety questions
- Give medical and strategic safety input to the Vicore Drug Safety Council and oversee IDMCs
- Participate in the development of innovative, cost- and time-effective, and scientifically sound clinical development plans
- Providing leadership to the development of key clinical trial documents
- Contributing to the development of regulatory documents
Your qualifications include over three years of experience in the pharmaceutical and/or biotechnology industry, where you have been actively involved in the clinical development of investigational new drugs. This experience extended to your role as the Sponsor’s medical expert, where you have been responsible for overseeing trials managed through global clinical outsourcing. Additionally, you have contributed to regulatory documents and submissions, and engaged in interactions with health authorities.
You are a medical doctor with hands-on pulmonology/ILD trial experience.
You are a person who possesses a dynamic combination of qualities, including initiative, organizational skills, and the ability to seamlessly handle multiple tasks. Your communication style is characterized by clarity, making you an adept leader in scientific and clinical settings. Your proactive approach, commitment, and energy set you apart. With exceptional problem-solving abilities and a “can-do attitude,” you thrive in challenging situations. Furthermore, your open and approachable personality makes you a pleasure to work with.
Vicore Pharma is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs, angiotensin II type 2 receptor agonists (ATRAG), for severe diseases.
Vicore has a unique expertise in the ATRAG biology and a holistic approach in diseases where the angiotensin II type 2 receptor has a central role in stopping and reversing disease pathology. Vicore’s pipeline has several assets with long patent life for a variety of diseases. Our lead indication is idiopathic pulmonary fibrosis and our most advanced candidate drug, C21, is currently completing a phase 2a clinical trial and preparing for the next phase.
Vicore is a lean and agile organization with highly experienced professionals who cover the entire spectrum from early asset development through to commercialization and patient access. Vicore’s success hinges on the capacity to attract and retain talented individuals who are deeply committed, adaptable to change, and thrive in a dynamic environment with ambitious goals. All employees are equally important to turn the Vicore ambition into reality. Through valuing trust, integrity, and an open, friendly, and informal atmosphere, you can expect great opportunities for impact and growth.
Travelling: Approx. 10 days per year.
Domicile: Commuting distance from the Vicore office in Hørsholm, Copenhagen.
For more details about the job or the company, please contact Director Life Science Gert Andersen, Unique Human Capital on M: +45 42 95 08 83, [email protected].
All applications must be in English and are treated confidentially.
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Jobbet er oprettet på vores service den 11.9.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Øvrige
Statistik over udbudte jobs som øvrige
Herunder ser du udviklingen i udbudte øvrige over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
Se flere statistikker her:
Statistik over udbudte øvrige over tid
Dato | Alle jobs som øvrige |
---|---|
26. november 2024 | 4015 |
25. november 2024 | 4027 |
24. november 2024 | 4132 |
23. november 2024 | 4143 |
22. november 2024 | 4161 |
21. november 2024 | 4133 |
20. november 2024 | 4187 |
19. november 2024 | 4123 |
18. november 2024 | 4122 |
17. november 2024 | 4267 |
16. november 2024 | 4283 |
15. november 2024 | 4388 |
14. november 2024 | 4313 |
13. november 2024 | 4270 |
12. november 2024 | 4213 |
11. november 2024 | 4206 |
10. november 2024 | 4294 |
9. november 2024 | 4332 |
8. november 2024 | 4278 |
7. november 2024 | 4231 |
6. november 2024 | 4215 |
5. november 2024 | 4135 |
4. november 2024 | 4080 |
3. november 2024 | 4275 |
2. november 2024 | 4293 |
1. november 2024 | 4340 |
31. oktober 2024 | 4480 |
30. oktober 2024 | 4371 |
29. oktober 2024 | 4402 |
28. oktober 2024 | 4362 |
27. oktober 2024 | 4444 |